Prenatal exposure to anti-epileptic drug valproate is associated with a more than 3-fold increase in the risk of intellectual disability and delayed childhood milestones, a recent population study shows.
Prenatal exposure to anti-epileptic drug valproate is associated with a more than 3-fold increase in the risk of intellectual disability and delayed childhood milestones, a recent population study shows.